It also boosts immune function by feeding our immune system as it helps regulate and activate the viral and bacteria-fighting immune cells
Chutima Roomruangwong, Chulalongkorn University, Thailand Updates Copyright 2023 da Silva Schmidt, Trettim, Longoni, Grings, de Matos, de Avila Quevedo, Ardais, Nedel, Ghisleni, Leipnitz, Pinheiro and de Assis
What we know: Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously Phase 2/3 trials show 24-29% weight loss at highest doses Side effects are similar to other incretin medications (mainly GI) It may be particularly effective for liver fat reduction FDA approval is potentially years away What to consider: Approved alternatives (semaglutide, tirzepatide) have established safety profiles "GLP-3" marketing may oversimplify or mislead Investigational drugs carry unknown long-term risks Quality control for compounded versions is variable Clinical trial results don't always translate to real-world outcomes The bigger picture: Retatrutide may represent a genuine advance in obesity treatmentthe data is genuinely impressive
Lets see what sets this medical weight loss program with GLP-1 medications apart from other weight management solutions available